Certified by Founder Lodge
PreciseDx
United States - New York, NY
START UP
1 Disclosed Funding Rounds $20,700,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
PreciseDx® is innovating oncology diagnostics, leveraging Artificial Intelligence (AI) for revolutionary, morphology-driven, disease analysis. Combining AI with our patented Morphology Featur
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 22 ,2024 | Series B | $20,700,000 |
Eventide Asset Management
Labcorp
Quest Diagnostics
Xsensio
CND Life Sciences
NYBC Ventures
PinkDx, Inc.
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
